Paxman AB (publ) (STO:PAX)
68.20
+0.20 (0.29%)
Oct 31, 2025, 12:59 PM CET
Paxman AB Revenue
Paxman AB had revenue of 77.49M SEK in the quarter ending June 30, 2025, with 17.76% growth. This brings the company's revenue in the last twelve months to 283.78M, up 14.42% year-over-year. In the year 2024, Paxman AB had annual revenue of 263.20M with 19.30% growth.
Revenue (ttm)
283.78M
Revenue Growth
+14.42%
P/S Ratio
5.59
Revenue / Employee
2.03M
Employees
105
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 263.20M | 42.59M | 19.30% |
| Dec 31, 2023 | 220.61M | 63.86M | 40.74% |
| Dec 31, 2022 | 156.75M | 52.04M | 49.70% |
| Dec 31, 2021 | 104.71M | 21.57M | 25.95% |
| Dec 31, 2020 | 83.14M | -12.53M | -13.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |